drugset / Trial / NCT02436889
Treatment of Incontinence Without Memory Problems
RandomizedParallel-groupTriple-blindTreatment
Summary
An 8-week randomized, controlled, pilot clinical trial of Mirabegron compared to a standard anticholinergic therapy (Detrol LA) in elderly women with urgency urinary incontinence.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-12
- Completion
- 2018-07
Outcome
Missed primary endpoint
registry analysis (superiority test); Mirabegron vs Tolterodine Tartrate; p = 0.949; ANCOVA NCT02436889 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 25 mg | Oral |
| Subject | Mirabegron | Other / unclassified | 50 mg | Oral |
| Comparator | Tolterodine | Unknown | 4 mg | Oral |